PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
07-Jan-2021 Turbine Raises EUR 5.7M to Advance Simulation-first Oncology Pipeline Turbine
07-Jan-2021 Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones Evelo Biosciences
07-Jan-2021 Aker BioMarine collaborates with University of Illinois Chicago Aker BioMarine
07-Jan-2021 Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies Theolytics
07-Jan-2021 Rinri Therapeutics Appoints Terri Gaskell, PhD as Chief Technology Officer Rinri Therapeutics
06-Jan-2021 WuXi STA’s Integrated CMC Platform Supports InnoCare Orelabrutinib Approved by NMPA WuXi STA
06-Jan-2021 Exostar Receives Kantara Initiative’s Identity Assurance Trust Framework Certification, Achieves Healthcare and Life Science Community Milestones Exostar
06-Jan-2021 Autolus Therapeutics provides business outlook for 2021 & 2022 Autolus Therapeutics
06-Jan-2021 Biotech Team Develops ELISA Protocol for COVID-19 IgG Antibody Detection ZTA Biotech
06-Jan-2021 Amolyt Pharma obtient la désignation de médicament orphelin de la FDA pour l’AZP-3601 pour le traitement potentiel de l’hypoparathyroïdie Andrew Lloyd Associates
06-Jan-2021 Amolyt Pharma obtient la désignation de médicament orphelin de la FDA pour l’AZP-3601 pour le traitement potentiel de l’hypoparathyroïdie Andrew Lloyd Associates
05-Jan-2021 Sosei Heptares to Regain Worldwide Rights to Muscarinic Agonist Programs Sosei Group Corporation
05-Jan-2021 iTeos to Present at the 39th Annual J.P. Morgan Healthcare Conference iTeos Therapeutics, Inc.
05-Jan-2021 Companion Diagnostics Market: Increasing demand for next-generation sequencing Markets and Markets
04-Jan-2021 Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference SMi Group
31-Dec-2020 ImmVira Announces Series C Financing with Leading Specialist Investors Immvira Group Company
31-Dec-2020 Glenmark receives one ANDA approval and two tentative ANDA approvals - Tadalafil Gabapentin Enacarbil and Apremilast Glenmark Pharmaceuticals Ltd
30-Dec-2020 SQI Diagnostics Announces $4 Million Funding via Warrant Exercise by Insiders SQI Diagnostics Inc.
30-Dec-2020 Protalix BioTherapeutics Issues 2020 Letter to Shareholders Protalix BioTherapeutics, Inc.
30-Dec-2020 New number of shares and votes in Cantargia Cantargia AB